M. Galanski

9.2k total citations · 2 hit papers
193 papers, 8.0k citations indexed

About

M. Galanski is a scholar working on Oncology, Organic Chemistry and Materials Chemistry. According to data from OpenAlex, M. Galanski has authored 193 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Oncology, 93 papers in Organic Chemistry and 48 papers in Materials Chemistry. Recurrent topics in M. Galanski's work include Metal complexes synthesis and properties (116 papers), Ferrocene Chemistry and Applications (51 papers) and Lanthanide and Transition Metal Complexes (40 papers). M. Galanski is often cited by papers focused on Metal complexes synthesis and properties (116 papers), Ferrocene Chemistry and Applications (51 papers) and Lanthanide and Transition Metal Complexes (40 papers). M. Galanski collaborates with scholars based in Austria, Germany and Russia. M. Galanski's co-authors include Bernhard K. Keppler, Michael A. Jakupec, Vladimir B. Arion, Christian G. Hartinger, V.B. Arion, Alexander Roller, Walter Berger, Hristo P. Varbanov, Seied M. Valiahdi and Petra Heffeter and has published in prestigious journals such as Water Research, Biochemistry and Chemical Communications.

In The Last Decade

M. Galanski

192 papers receiving 7.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antitumour metal compounds: more than theme and variations

2007 761 citations Michael A. Jakupec, M. Galanski et al. Dalton Transactions profile →
Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches

2005 631 citations M. Galanski, Michael A. Jakupec et al. Current Medicinal Chemistry profile →

Peers

Countries citing papers authored by M. Galanski

Since Specialization

Citations

This map shows the geographic impact of M. Galanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Galanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Galanski more than expected).

Fields of papers citing papers by M. Galanski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Galanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Galanski. The network helps show where M. Galanski may publish in the future.

Co-authorship network of co-authors of M. Galanski

This figure shows the co-authorship network connecting the top 25 collaborators of M. Galanski. A scholar is included among the top collaborators of M. Galanski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Galanski. M. Galanski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Combination of Drug Delivery Properties of PAMAM Dendrimers and Cytotoxicity of Platinum(IV) Complexes—A More Selective Anticancer Treatment? 2023 ·Pharmaceutics ·(unknown), Michaela Hejl, (unknown), Michael A. Jakupec, Walter Berger, M. Galanski, Bernhard K. Keppler	4
2	Not the usual suspect – an unexpected organometallic product during the synthesis of cytotoxic platinum(ii) complexes 2023 ·Dalton Transactions ·Thomas Maier, (unknown), (unknown), Michaela Hejl, Klaudia Cseh, Sebastian Mai, Michael A. Jakupec, M. Galanski, Bernhard K. Keppler	1
3	Quaternary Ammonium Palmitoyl Glycol Chitosan (GCPQ) Loaded with Platinum-Based Anticancer Agents—A Novel Polymer Formulation for Anticancer Therapy 2023 ·Pharmaceuticals ·(unknown), Michaela Hejl, (unknown), (unknown), (unknown), (unknown), (unknown), Michael A. Jakupec, Andreas G. Schätzlein, Ijeoma F. Uchegbu, M. Galanski, Bernhard K. Keppler	1
4	The impact of whole human blood on the kinetic inertness of platinum(iv) prodrugs – an HPLC-ICP-MS study 2018 ·Dalton Transactions ·Sarah Theiner, Márkó Grabarics, (unknown), Hristo P. Varbanov, (unknown), M. Galanski, Bernhard K. Keppler, Gunda Koellensperger	21
5	A fluorescent oxaliplatin derivative for investigation of oxaliplatin resistance using imaging techniques 2017 ·JBIC Journal of Biological Inorganic Chemistry ·Ganna V. Kalayda, (unknown), M. Galanski, (unknown)	8
6	Inductively coupled plasma mass spectrometry for metallodrug development: Albumin binding and serum distribution of cytotoxic cis- and trans-isomeric platinum(II) complexes 2014 ·Journal of Inorganic Biochemistry ·(unknown), (unknown), И. Ф. Серегина, M. Galanski, Bernhard K. Keppler, Andrei R. Timerbaev, Mikhail A. Bolshov	27
7	Diamminetetrakis(carboxylato)platinum(IV) Complexes – Synthesis, Characterization, and Cytotoxicity 2012 ·Chemistry & Biodiversity ·(unknown), (unknown), Michael A. Jakupec, M. Galanski, Bernhard K. Keppler	11
8	Capillary zone electrophoresis and capillary zone electrophoresis–electrospray ionization mass spectrometry studies on the behavior of anticancer cis- and trans-[dihalidobis(2-propanone oxime)platinum(II)] complexes in aqueous solutions 2012 ·Journal of Chromatography A ·(unknown), Samuel M. Meier, (unknown), M. Galanski, Bernhard K. Keppler, Christian G. Hartinger	17
9	Water‐Soluble Cationic Derivatives of Indirubin, the Active Anticancer Component from Indigo naturalis 2012 ·Chemistry & Biodiversity ·(unknown), Alexander Egger, Gerhard Mühlgassner, Vladimir B. Arion, Michael A. Jakupec, M. Galanski, Walter Berger, Bernhard K. Keppler	6
10	Ionic liquids for extraction of metals and metal containing compounds from communal and industrial waste water 2011 ·Water Research ·Lisa Fischer, (unknown), Gunda Koellensperger, Anja Stojanovic, Daniel Kogelnig, M. Galanski, Regina Krachler, Bernhard K. Keppler, Stephan Hann	148
11	Phosphonium and Ammonium Ionic Liquids with Aromatic Anions: Synthesis, Properties, and Platinum Extraction* 2010 ·Australian Journal of Chemistry ·Anja Stojanovic, Daniel Kogelnig, Lisa Fischer, Stephan Hann, M. Galanski, Michael Groessl, Regina Krachler, Bernhard K. Keppler	73
12	Novel bis(carboxylato)dichlorido(ethane-1,2-diamine)platinum(IV) complexes with exceptionally high cytotoxicity 2008 ·Journal of Inorganic Biochemistry ·Michael R. Reithofer, (unknown), Seied M. Valiahdi, M. Galanski, Michael A. Jakupec, Bernhard K. Keppler	36
13	Searching for the Magic Bullet: Anticancer Platinum Drugs Which Can Be Accumulated or Activated in the Tumor Tissue 2007 ·Anti-Cancer Agents in Medicinal Chemistry ·M. Galanski, Bernhard K. Keppler	125
14	Recent Developments in the Field of Anticancer Platinum Complexes 2006 ·Recent Patents on Anti-Cancer Drug Discovery ·M. Galanski	188
15	Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches breakdown → 2005 ·Current Medicinal Chemistry ·M. Galanski, Michael A. Jakupec, Bernhard K. Keppler	631
16	Synthesis and structure-activity relationships of mono- and dialkyl-substituted oxaliplatin derivatives 2005 ·European Journal of Medicinal Chemistry ·Ladislav Habala, M. Galanski, (unknown), Alexey A. Nazarov, (unknown), Bernhard K. Keppler	40
17	Design, synthesis, physical and chemical characterisation, and biological interactions of lectin-targeted latex nanoparticles bearing Gd–DTPA chelates: an exploration of magnetic resonance molecular imaging (MRMI) 2005 ·Histochemistry and Cell Biology ·(unknown), Christian Kremser, (unknown), (unknown), Hermann Dietrich, Heribert Talasz, Yiping Zou, Beate Hugl, M. Galanski, E. Sölder, Kristian Pfaller, (unknown), Wolfgang Buchberger, Bernhard K. Keppler, Paul Debbage	27
18	Recent Developments in the Field of Tumor-Inhibiting Metal Complexes 2003 ·Current Pharmaceutical Design ·M. Galanski, V.B. Arion, Michael A. Jakupec, Bernhard K. Keppler	452
19	Kinetics of binding properties of 5′-GMP with cisplatin under simulated physiological conditions by capillary electrophoresis 2000 ·Journal of Chromatography B Biomedical Sciences and Applications ·(unknown), M. Galanski, Thomas Bereuter, Bernhard K. Keppler, Wolfgang Lindner	33
20	Angiosarcoma of the Liver Presenting with Esophageal Bleeding and Arterio-portal Shunts 2000 ·Journal of Hepatology ·Jürgen Rademaker, A. Widjaja, Michael P. Manns, M. Galanski	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact